← Back to Search

Dietary Supplement

Calcium Carbonate for Labor Induction

Phase 1
Recruiting
Led By Marie Forgie, DO
Research Sponsored by Aurora Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the intervention (time on calcium carbonate to delivery)
Awards & highlights

Summary

This trial aims to study if giving calcium carbonate to women in labor can make the labor process faster and safer. Researchers believe that calcium carbonate can reduce the need for certain medications during labor, lower the chances

Who is the study for?
This trial is for pregnant individuals who are about to undergo labor induction. The specific details on eligibility criteria were not provided, so it's important to consult with the study organizers for more information.
What is being tested?
The trial is testing if calcium carbonate can help during labor induction by reducing the time and dosage of oxytocin needed, lowering the chances of difficult labor (dystocia), and cutting down cesarean deliveries without harming mother or baby.
What are the potential side effects?
While detailed side effects are not listed, calcium carbonate is generally considered low-risk. Possible side effects may include digestive discomfort like gas or constipation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the intervention (time from duration of induction with oxytocin start to delivery)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the intervention (time from duration of induction with oxytocin start to delivery) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Duration of induction time
Rate of labor dystocia
Secondary study objectives
Blood loss
Gastrointestinal side effects
Neonatal composite adverse outcomes
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Prospective Treatment GroupExperimental Treatment1 Intervention
Patients receive calcium carbonate (500mg every 4 hours, per standardized treatment protocol) plus standard-dose oxytocin for labor induction
Group II: Retrospective Historical Control GroupActive Control1 Intervention
Patients who presented for induction at the same institution within the previous three years and received standard-dose oxytocin alone for labor induction and were not treated with calcium carbonate
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Calcium Carbonate
2011
Completed Phase 4
~7320

Find a Location

Who is running the clinical trial?

Aurora Health CareLead Sponsor
45 Previous Clinical Trials
16,168 Total Patients Enrolled
Marie Forgie, DOPrincipal InvestigatorAurora Health Care
~125 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top